UnknownNot Applicable

Mhealth Application for anTicoagulation Care in Atrial Fibrillation

200 participantsStarted 2017-06

Plain-language summary

This study will assess the benefits of using a mobile health application designed for shared decision aid in anticoagulation therapy in patients with Atrial Fibrillation (AF). The aim is to improve their treatment adherence and time in therapeutic International Normalized Ratio (INR) range. The results of this study have the potential to lead to a sustainable and resource-efficient strategy for better prevent thromboembolic events in patients with atrial fibrillation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults \>=18 years * Diagnostic of atrial fibrillation * Indication of oral anticoagulation by their physician, based on risk scores * Ability to speak, hear and understand Portuguese * Able to receive and read text messages through a cell phone Exclusion Criteria: Physical impairments that prevent completion of the intervention, cognitive impairments that jeopardize informed consent and/or intervention comprehension and not fluent in Portuguese.

What they're measuring

Oral anticoagulant adherence

Timeframe: 6 months

Percent time in therapeutic INR (TTR)

Timeframe: 6 months

Trial details

NCT IDNCT03174093

SponsorInstituto de Cardiologia do Rio Grande do Sul

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06

Contact for this trial

Tiago Luiz L Leiria, MD PhD

(+55) 51 85744494 drleiria@gmail.com

View on ClinicalTrials.gov More Atrial Fibrillation trials